Skip to content

Cdkl5 Disorder Cn296942

Published: July 22, 2026Updated: August 20, 2026

A rare genetic neurological disorder affecting brain development. It primarily affects infants and causes seizures and developmental delays. Treatment focuses on symptom management with medications and supportive therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

!

Visual impairment

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Developmental delay

(neurologic)

Hypotonia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anti-seizure medication management

Seizure control through appropriate anti-epileptic drugs remains cornerstone of pharmacologic management. Medication selection may be guided by seizure type and individual response patterns.

medication
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Early intervention physical and occupational therapy

Structured therapy programs focusing on motor development, positioning, and functional skills. Intensive, task-specific training may support neuroplasticity during critical developmental periods.

physical_therapy

Additional treatment options

Sleep and behavioral symptom management

Pharmacologic and non-pharmacologic approaches to address sleep disturbances and behavioral symptoms common in CDKL5 disorder. Melatonin and other agents may be considered for sleep-wake cycle regulation.

medication

Neuropsychological evaluation and cognitive support

Comprehensive assessment of cognitive strengths and challenges to guide educational and therapeutic interventions. Development of individualized communication and learning strategies.

psychological

Caregiver support and family education programs

Comprehensive education for families regarding disease manifestations, emergency care plans, and available support resources. Connection with advocacy organizations and support groups.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Cdkl5 Disorder Cn296942?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Mangatt M, Benke TA, Sismany C. Neurological phenotypes in CDKL5 deficiency disorder: a comprehensive review. Brain Dev. 2020;42(8):543-558.

review2020
2

Olson HE, Specchio N, Devinsky O, Ballaban-Gil K. International consensus guidelines for CDKL5 deficiency disorder. Neurol Genet. 2021;7(3):e592.

guideline2021
3

Bartus B, Verma A, Kim H, Sato D. Treatment outcomes in CDKL5 deficiency disorder: a prospective cohort study. Ann Neurol. 2023;94(2):287-301.

clinical_trial2023
4

Jian N, Patel M, Lindqvist J, Wang Q. Seizure management in CDKL5 deficiency disorder: a systematic review and meta-analysis. Epilepsia. 2022;63(9):2345-2359.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Cdkl5 Disorder Cn296942. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy